IRadimed Corporation provided earnings guidance for the third quarter and for the full year of 2023. For the quarter, the company expects to report revenue of $16.1 million to $16.3 million, GAAP diluted earnings per share of $0.33 to $0.35.

For the year, the company now expects to report revenue of $64.5 million to $65.5 million, GAAP diluted earnings per share of $1.25 to $1.28.